Drug: GLUCOVANCE Injury: Pancreatic carcinoma metastatic Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 104446043 | GLUCOVANCE | Pancreatic carcinoma metastatic | MERCK | 77.00 YR | M | 134 KG | 20160915 | US |
| 124382974 | GLUCOVANCE | Pancreatic carcinoma metastatic | GLAXOSMITHKLINE | 66.38 YR | F | 68 KG | 20160722 | US |
| 124510323 | GLUCOVANCE | Pancreatic carcinoma metastatic | NOVO NORDISK | 66.00 YR | F | 68 KG | 20160726 | US |
| 125666961 | GLUCOVANCE | Pancreatic carcinoma metastatic | BRISTOL MYERS SQUIBB | 66.38 YR | F | 69 KG | 20160718 | US |
| 126858251 | GLUCOVANCE | Pancreatic carcinoma metastatic | AVENTIS | 66.00 YR | F | 69 KG | 20160825 | US |
Total Records: 5 Number of Pages: 1